139 related articles for article (PubMed ID: 2185565)
21. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.
Nemunaitis J; Rosenfeld CS; Ash R; Freedman MH; Deeg HJ; Appelbaum F; Singer JW; Flomenberg N; Dalton W; Elfenbein GJ
Bone Marrow Transplant; 1995 Jun; 15(6):949-54. PubMed ID: 7581096
[TBL] [Abstract][Full Text] [Related]
22. Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defense.
Gutterman J; Vadhan-Raj S; Logothetis C; Anaissle E; Estey E; Talpaz M; Kurzrock R
Semin Hematol; 1990 Jul; 27(3 Suppl 3):15-24. PubMed ID: 2198660
[TBL] [Abstract][Full Text] [Related]
23. Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.
Gerhartz HH; Visani G; Delmer A; Zwierzina H; Ribeiro M; Jacobs A; Marcus R; Baumelou M; Fière D; Labar B
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():36-7. PubMed ID: 2697397
[No Abstract] [Full Text] [Related]
24. Clinical role of granulocyte-macrophage colony-stimulating factor.
Mitsuyasu RT; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
[TBL] [Abstract][Full Text] [Related]
25. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
26. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
[TBL] [Abstract][Full Text] [Related]
27. Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor.
Greenberg P; Negrin R; Nagler A; Souza L; Donlon T
Prog Clin Biol Res; 1990; 338():151-61. PubMed ID: 1693211
[No Abstract] [Full Text] [Related]
28. Hematopoietic growth factors in marrow transplantation and radiation injury.
Storb R; Appelbaum F; Nemunaitis J; Schuening F; Singer J; Epstein C; Buckner CD; Souza LM; Thomas ED
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():116-20. PubMed ID: 1697190
[No Abstract] [Full Text] [Related]
29. [GM-CSF: its use in onco-hematologic diseases].
Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
[No Abstract] [Full Text] [Related]
30. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic bone marrow transplantation using unrelated marrow donors.
Fay JW; Collins RH; Piñeiro L
Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
[No Abstract] [Full Text] [Related]
32. Granulocyte-macrophage colony-stimulating factor and myelodysplastic syndromes.
N Engl J Med; 1988 Jul; 319(1):51-3. PubMed ID: 3288869
[No Abstract] [Full Text] [Related]
33. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
Yamashita J; Kawamura T; Shoin K
No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
[No Abstract] [Full Text] [Related]
34. Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
Hoelzer D; Ganser A; Greher J; Völkers B; Walther F
Behring Inst Mitt; 1988 Aug; (83):134-8. PubMed ID: 3071328
[TBL] [Abstract][Full Text] [Related]
35. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
Klingemann HG; Eaves AC; Barnett MJ; Reece DE; Shepherd JD; Belch AR; Brandwein JM; Langleben A; Koch PA; Phillips GL
Clin Invest Med; 1990 Apr; 13(2):77-81. PubMed ID: 2191816
[TBL] [Abstract][Full Text] [Related]
36. The myelodysplastic syndromes: biology and implications for management.
List AF; Garewal HS; Sandberg AA
J Clin Oncol; 1990 Aug; 8(8):1424-41. PubMed ID: 1696311
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes.
Hoelzer D; Ganser A; Völkers B; Greher J; Walther F
Blood Cells; 1988; 14(2-3):551-9. PubMed ID: 3067785
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) following autologous marrow transplantation in man.
Appelbaum FR; Nemunaitis J
Behring Inst Mitt; 1988 Aug; (83):145-8. PubMed ID: 3071330
[TBL] [Abstract][Full Text] [Related]
39. The promise of colony-stimulating factors in clinical practice.
Glaspy JA; Ambersley JM
Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
[TBL] [Abstract][Full Text] [Related]
40. Colony-stimulating factors in the treatment of HIV-associated non-Hodgkin's lymphoma.
Walsh C
Oncology (Williston Park); 1989 Oct; 3(10):79-83; discussion 84-6. PubMed ID: 2701212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
